Authors: NORDAL RR KRISTENSEN GB STENWIG AE TROPE CG NESLAND JM

Citation: Rr. Nordal et al., IMMUNOHISTOCHEMICAL ANALYSIS OF P53 PROTEIN IN UTERINE SARCOMAS, Gynecologic oncology (Print), 70(1), 1998, pp. 45-48

Authors: NORDAL RR THORESEN SO

Citation: Rr. Nordal et So. Thoresen, UTERINE SARCOMAS IN NORWAY 1956-1992 - INCIDENCE, SURVIVAL AND MORTALITY, European journal of cancer, 33(6), 1997, pp. 907-911

Authors: NORDAL RR KRISTENSEN GB STENWIG AE NESLAND JM PETTERSEN EO TROPE CG

Citation: Rr. Nordal et al., AN EVALUATION OF PROGNOSTIC FACTORS IN UTERINE CARCINOSARCOMA, Gynecologic oncology, 67(3), 1997, pp. 316-321

Authors: NORDAL RR KRISTENSEN GB KAERN J STENWIG AE PETTERSEN EO TROPE CG

Citation: Rr. Nordal et al., THE PROGNOSTIC-SIGNIFICANCE OF SURGERY, TUMOR SIZE, MALIGNANCY GRADE,MENOPAUSAL STATUS, AND DNA-PLOIDY IN ENDOMETRIAL STROMAL SARCOMA, Gynecologic oncology, 62(2), 1996, pp. 254-259

Authors: NORDAL RR KRISTENSEN GB KAERN J STENWIG AE PETTERSEN EO TROPE CG

Citation: Rr. Nordal et al., THE PROGNOSTIC-SIGNIFICANCE OF STAGE, TUMOR SIZE, CELLULAR ATYPIA ANDDNA-PLOIDY IN UTERINE LEIOMYOSARCOMA, Acta oncologica, 34(6), 1995, pp. 797-802